XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
NET (LOSS) INCOME PER SHARE (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of computation of net (loss) income per share
The computation of net (loss) income per share is as follows (in thousands, except per share amounts):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Basic net (loss) income per share:
Numerator
Net (loss) income$(544,635)$406,100 $(2,067,948)$2,783,912 
Less: Income allocated to participating securities— (3,757)— (542,122)
Net (loss) income attributable to common stockholders, basic$(544,635)$402,343 $(2,067,948)$2,241,790 
Denominator
Weighted-average shares of common stock used to compute net (loss) income per share attributable to common stockholders, basic223,916 209,604 220,816 165,045 
Net (loss) income per share attributable to common stockholders, basic$(2.43)$1.92 $(9.37)$13.58 
Diluted net (loss) income per share:
Numerator
Net (loss) income$(544,635)$406,100 $(2,067,948)$2,783,912 
Less: Income allocated to participating securities— (3,167)— (448,463)
Add: Interest on convertible notes, net of tax— 3,087 — 3,638 
Less: Fair value gain on contingent consideration arrangement, net of tax — (680)(5,395)(680)
Net (loss) income attributable to common stockholders, diluted$(544,635)$405,340 $(2,073,343)$2,338,407 
Denominator
Weighted-average shares of common stock used to compute net (loss) income per share attributable to common stockholders, basic223,916 209,604 220,816 165,045 
Weighted-average effect of potentially dilutive securities:
Stock options— 33,122 — 38,419 
RSUs— 3,924 — 3,604 
Restricted common stock— — 
Warrants— — — 97 
Convertible notes— 3,880 — 1,883 
Contingent consideration— 40 
Weighted-average shares of common stock used to compute net (loss) income per share attributable to common stockholders, diluted223,916 250,536 220,856 209,052 
Net (loss) income per share attributable to common stockholders, diluted$(2.43)$1.62 $(9.39)$11.19 
Schedule of potentially dilutive shares
The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive (in thousands):
Three Months Ended September 30Nine Months Ended September 30
2022 202120222021
Stock options33,411 6,134 33,411 6,134 
RSUs6,854 107 6,854 107 
Convertible notes3,880 — 3,880 — 
Restricted common stock1,740 65 1,740 65 
ESPP1,030 284 1,030 284 
Contingent consideration76 — — — 
Total46,991 6,590 46,915 6,590